Lymphogranuloma venereum natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Natural History== | ==Natural History== | ||
===Primary | ===Primary Stage=== | ||
*Incubation period of ''Chlamydia trachomatis'' is approximately 3 to 30 days, after which a [[papule]] develops at the point of inoculation. | *Incubation period of ''Chlamydia trachomatis'' is approximately 3 to 30 days, after which a [[papule]] develops at the point of inoculation. | ||
*The papule may [[Ulcer|ulcerate]]. | *The papule may [[Ulcer|ulcerate]]. | ||
| Line 10: | Line 10: | ||
*Individuals with rectal exposure may develop [[proctitis]]. | *Individuals with rectal exposure may develop [[proctitis]]. | ||
===Secondary | ===Secondary Stage=== | ||
*[[Lymphadenopathy]] develops approximately 2 to 6 weeks after onset of the primary lesion. | *[[Lymphadenopathy]] develops approximately 2 to 6 weeks after onset of the primary lesion. | ||
*If the site of inoculation is on the anterior area of genitalia, patients most commonly develop [[inguinal]] and/ or [[femoral]] [[lymphadenitis]]. | *If the site of inoculation is on the anterior area of genitalia, patients most commonly develop [[inguinal]] and/ or [[femoral]] [[lymphadenitis]]. | ||
| Line 16: | Line 16: | ||
:*[[Lymphadenopathy]] is unilateral is two-thirds of patients. | :*[[Lymphadenopathy]] is unilateral is two-thirds of patients. | ||
:*Lymph nodes may develop into fluctuant, suppurative [[buboes]] or nonsuppurative [[abscesses]] | :*Lymph nodes may develop into fluctuant, suppurative [[buboes]] or nonsuppurative [[abscesses]] | ||
:*Approximately 20% of patients develop "Groove sign".<ref name="pmid11589803">{{cite journal| author=Roest RW, van der Meijden WI, European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization| title=European guideline for the management of tropical genito-ulcerative diseases. | journal=Int J STD AIDS | year= 2001 | volume= 12 Suppl 3 | issue= | pages= 78-83 | pmid=11589803 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11589803 }} </ref> | :*Approximately 20% of patients develop "Groove sign" (separation of the inguinal and femoral lymph nodes by the inguinal ligament).<ref name="pmid11589803">{{cite journal| author=Roest RW, van der Meijden WI, European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization| title=European guideline for the management of tropical genito-ulcerative diseases. | journal=Int J STD AIDS | year= 2001 | volume= 12 Suppl 3 | issue= | pages= 78-83 | pmid=11589803 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11589803 }} </ref> | ||
*If site of inoculation is the posterior area of genitalia or anorectal area, patients commonly develop anorectal syndrome. | |||
:*Patients may develop [[lymphadenopathy]] of the [[iliac]] or [[perirectal]] nodes. | |||
:*Patients may develop [[proctocolitis]]. | |||
==Complications== | ==Complications== | ||
Revision as of 20:36, 22 February 2016
|
Lymphogranuloma venereum Microchapters |
|
Differentiating Lymphogranuloma venereum from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphogranuloma venereum natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Lymphogranuloma venereum natural history, complications and prognosis |
|
FDA on Lymphogranuloma venereum natural history, complications and prognosis |
|
CDC on Lymphogranuloma venereum natural history, complications and prognosis |
|
Lymphogranuloma venereum natural history, complications and prognosis in the news |
|
Blogs on Lymphogranuloma venereum natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.
Natural History
Primary Stage
- Incubation period of Chlamydia trachomatis is approximately 3 to 30 days, after which a papule develops at the point of inoculation.
- The papule may ulcerate.
- The lesion is self-limited and heals in approximately 1 week.
- Individuals with rectal exposure may develop proctitis.
Secondary Stage
- Lymphadenopathy develops approximately 2 to 6 weeks after onset of the primary lesion.
- If the site of inoculation is on the anterior area of genitalia, patients most commonly develop inguinal and/ or femoral lymphadenitis.
- Inflammation is more common in men and occurs in approximately 20% of women.
- Lymphadenopathy is unilateral is two-thirds of patients.
- Lymph nodes may develop into fluctuant, suppurative buboes or nonsuppurative abscesses
- Approximately 20% of patients develop "Groove sign" (separation of the inguinal and femoral lymph nodes by the inguinal ligament).[1]
- If site of inoculation is the posterior area of genitalia or anorectal area, patients commonly develop anorectal syndrome.
- Patients may develop lymphadenopathy of the iliac or perirectal nodes.
- Patients may develop proctocolitis.
Complications
Genital elephantiasis or esthiomene, which is the dramatic end-result of lymphatic obstruction, which may occur because of the strictures themselves, or fistulas. This is usually seen in females, may ulcerate and often occurs 1-20 years after primary infection. Fistulas of, but not limited to, the penis, urethra, vagina, uterus, or rectum. Also, surrounding edema often occurs. Rectal or other strictures and scarring. Systemic spread may occur, possible results are arthritis, pneumonitis, hepatitis, or perihepatitis.
Prognosis
Highly variable. Spontaneous remission is common. Complete cure can be obtained with proper antibiotic treatment. Course is more favorable with early treatment. Bacterial superinfections may complicate course. Death can occur from bowel obstruction or perforation. Follicular conjunctivitis due to autoinoculation of infectious discharge.
References
- ↑ Roest RW, van der Meijden WI, European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization (2001). "European guideline for the management of tropical genito-ulcerative diseases". Int J STD AIDS. 12 Suppl 3: 78–83. PMID 11589803.